Ethyl 5-(piperazin-1-yl)benzofuran-2-carboxylate hydrochloride, 98%, 100g

4-Chloro-2-ethynylaniline, 98%, 10g

3-(Trifluoromethyl)-5,6,7,8-tetrahydro-1,6-naphthyridine dihydrochloride, 97%, 1g

2-(Benzyloxy)-1-bromo-3-nitrobenzene, 98%, 500g

(S)-N-(2-(4-(tert-Butyl)-4,5-dihydrooxazol-2-yl)phenyl)quinoline-2-carboxamide, 1g

Dibenzo[g,p]chrysene, 98%, 250mg

(1R,2R)-N1,N1,N2-Trimethylcyclohexane-1,2-diamine, 97.0%, 1g

Acido 4-nitrobenzoico, minimo 99,5%, 100 g, confezione in plastica.

2-(3-Methyl-3H-diazirin-3-yl)ethanol, 95.0%, 1g

3-Bromo-4-(propan-2-yloxy)aniline hydrochloride, 95%, 1g

3-(2-NITRO-PHENYLAMINO)-8-AZA-BICYCLO[3.2.1]OCTANE-8-CARBOXYLIC ACID ETHYL ESTER, 95.0%, 250mg

Soluzione standard ICP di sodio, 500 ml, 1 000 mg/L Na, HDPE

4-Bromo-1-ethyl-1 H -pyrazole-3-carboxylic acid, 95.0%, 100mg